GENEVA, June 23 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/062402) for "RNA MOLECULES" on Dec 10, 2024. With publication no. WO/2025/126019, the details related to the patent application was published on Jun 19, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MCMONAGLE, Patricia Michele (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965), SILMON DE MONERRI, Natalie Clare (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965)
Abstract:
The present disclosure relates to RNA molecules encoding a Nei...